Adaptive Biotechnologies Corporation(ADPT)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | -5,000 | -1.20%411,775 | $19.00 | $95,000 | View SEC filing | |
| 2026-06-08 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | -11,000 | -2.57%416,775 | $18.00 | $198,000 | View SEC filing | |
| 2026-06-08 | LO FRANCIS Chief People Officer | Sale | -39,741 | -13.67%250,934 | $17.49 | $695,070 | View SEC filing | |
| 2026-05-20 | PISKEL KYLE Chief Financial Officer | Sale | -3,115 | -1.20%256,725 | $13.04 | $40,620 | View SEC filing | |
| 2026-04-27 | RUBINSTEIN JULIE President and COO | Sale | -19,037 | -4.80%377,802 | $14.23 | $270,897 | View SEC filing | |
| 2026-04-24 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -6.77%382,132 | $13.96 | $798,423 | View SEC filing | |
| 2026-04-21 | RUBINSTEIN JULIE President and COO | Sale | -69,061 | -6.56%395,146 | $14.60 | $1,008,622 | View SEC filing | |
| 2026-04-16 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -6.36%408,160 | $14.45 | $826,251 | View SEC filing | |
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -6.18%421,174 | $13.26 | $758,108 | View SEC filing | |
| 2026-04-10 | ROBINS HARLAN S Chief Scientific Officer | Sale | -10,000 | -0.66%1,512,058 | $14.85 | $148,500 | View SEC filing | |
| 2026-04-10 | LO FRANCIS Chief People Officer | Sale | -22,564 | -7.68%271,154 | $15.07 | $340,039 | View SEC filing | |
| 2026-04-08 | RUBINSTEIN JULIE President and COO | Sale | -69,061 | -6.00%434,188 | $14.34 | $990,503 | View SEC filing | |
| 2026-04-08 | ROBINS CHAD M CEO and Chairman | Sale | -120,595 | -5.24%2,180,518 | $14.65 | $1,766,839 | View SEC filing | |
| 2026-04-02 | RUBINSTEIN JULIE President and COO | Sale | -38,120 | -4.97%447,202 | $14.53 | $553,693 | View SEC filing | |
| 2026-03-31 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -5.74%455,878 | $13.14 | $751,303 | View SEC filing | |
| 2026-03-26 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -5.58%468,892 | $14.03 | $802,235 | View SEC filing | |
| 2026-03-23 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -5.44%481,906 | $13.46 | $769,643 | View SEC filing | |
| 2026-03-18 | RUBINSTEIN JULIE President and COO | Sale | -57,180 | -5.31%494,920 | $13.33 | $762,209 | View SEC filing | |
| 2026-03-13 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | -41,338 | -8.81%427,775 | $13.17 | $544,421 | View SEC filing | |
| 2026-03-13 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale | -63,103 | -18.79%272,751 | $13.17 | $831,067 | View SEC filing | |
| 2026-03-13 | ROBINS HARLAN S Chief Scientific Officer | Sale | -470,266 | -23.60%1,522,058 | $13.17 | $6,193,403 | View SEC filing | |
| 2026-03-13 | RUBINSTEIN JULIE President and COO | Sale | -179,703 | -21.06%507,934 | $13.21 | $2,374,058 | View SEC filing | |
| 2026-03-13 | PISKEL KYLE Chief Financial Officer | Sale | -18,672 | -6.70%259,840 | $13.17 | $245,910 | View SEC filing | |
| 2026-03-13 | LO FRANCIS Chief People Officer | Sale | -30,593 | -9.50%291,374 | $14.08 | $430,749 | View SEC filing | |
| 2026-03-13 | ROBINS CHAD M CEO and Chairman | Sale | -470,167 | -16.97%2,301,113 | $13.17 | $6,192,099 | View SEC filing |
1-25 of 382